← Back to Search

Procedure

Pericardiotomy for Heart Failure

N/A
Waitlist Available
Led By Barry A Borlaug, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 30 years
Symptoms of severe dyspnea (III-IV) without evidence of a non-cardiac or ischemic explanation for dyspnea
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This study is evaluating whether a minimally invasive procedure can improve heart function and symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in left ventricular filling pressures during volume loading
Major Adverse Cardiac and Cerebrovascular Events
Secondary outcome measures
Change in Quality of Life
Change in exercise capacity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Subjects with Heart Failure with Preserved Ejection FractionExperimental Treatment1 Intervention
Subjects with Heart Failure with Preserved Ejection Fraction (HFpEF) will receive a minimally invasive treatment called a pericardiotomy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pericardiotomy
2019
N/A
~10

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,780 Total Patients Enrolled
72 Trials studying Heart Failure
1,022,024 Patients Enrolled for Heart Failure
Barry A Borlaug, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
122 Total Patients Enrolled
2 Trials studying Heart Failure
122 Patients Enrolled for Heart Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure
Barry Borlaug 2019. "Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03923673.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top